GSK chair and former AstraZeneca CFO Sir Jonathan Symonds says MedImmune carried “a premium on a premium”, at Jefferies London
In the Jefferies London keynote, GSK chair Sir Jonathan Symonds told Jefferies president Brian Friedman that MedImmune was the hardest deal of the AstraZeneca and Novartis years, and that industrial logic comes first.
